Dashboard
Manage Tickers

TERN


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

truist-securities-initiates-coverage-on-terns-pharma-with-buy-rating-announces-price-target-of-20
Truist Securities Initiates Coverage On Te...
10/15/2025 11:33:58

Truist Securities analyst Srikripa Devarakonda initiates coverage on Terns Pharma (NASDAQ:TERN) with a Buy rating and announ...

barclays-initiates-coverage-on-terns-pharma-with-overweight-rating-announces-price-target-of-15
Barclays Initiates Coverage On Terns Pharm...
09/17/2025 11:05:06

Barclays analyst Etzer Darout initiates coverage on Terns Pharma (NASDAQ:TERN) with a Overweight rating and announces Price ...

hc-wainwright--co-assumes-terns-pharma-at-neutral-announces-price-target-of-744
HC Wainwright & Co. Assumes Terns Pharma a...
09/04/2025 11:30:14

HC Wainwright & Co. analyst Andrew S. Fein assumes Terns Pharma (NASDAQ:TERN) with a Neutral rating and announces Price ...

eli-lillys-rare-weight-loss-data-miss-could-benefit-competitors
Eli Lilly's Rare Weight Loss Data Miss Cou...
08/07/2025 13:55:46

Eli Lilly's obesity drug data misses targets, boosting shares of Novo Nordisk, Viking, Structure, and Terns amid promising ...

terns-pharma-q2-eps-026-beats-030-estimate
Terns Pharma Q2 EPS $(0.26) Beats $(0.30) ...
08/05/2025 20:33:06

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.30) ...

terns-pharma-says-phase-2-falcon-clinical-trial-of-tern-601-completed-enrollment-12-week-data-expected-in-4q-2025
Terns Pharma Says Phase 2 FALCON Clinical ...
06/23/2025 20:10:16

terns-pharma-to-highlight-data-from-completed-phase-1-study-of-tern-601-once-daily-oral-glp-1r-agonist-at-ada-scientific-sessions
Terns Pharma To Highlight Data From Comple...
06/23/2025 20:09:19

Phase 1 clinical study of TERN-601 demonstrated differentiated profile in 28-day study; topline data were presented in Septembe...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
06/20/2025 12:09:39

insmed-tesla-caseys-general-stores-and-other-big-stocks-moving-higher-on-tuesday
Insmed, Tesla, Casey's General Stores And ...
06/10/2025 14:18:02

terns-pharmaceuticals-selected-for-oral-presentation-at-eha-congress-for-preclinical-data-on-novel-allosteric-bcr-abl-inhibitor-tern-701
Terns Pharmaceuticals Selected For Oral Pr...
05/14/2025 13:44:39

Preclinical data highlight improved potency vs. asciminib across multiple clinically relevant variants of BCR-ABL including dif...

bmo-capital-maintains-outperform-on-terns-pharma-lowers-price-target-to-15
BMO Capital Maintains Outperform on Terns ...
05/13/2025 16:46:35

BMO Capital analyst Etzer Darout maintains Terns Pharma (NASDAQ:TERN) with a Outperform and lowers the price target from $26...

terns-pharma-q1-eps-026-beats-028-estimate
Terns Pharma Q1 EPS $(0.26) Beats $(0.28) ...
05/08/2025 21:02:19

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.26) per share which beat the analyst consensus estimate of $(0.28) ...

jmp-securities-reiterates-market-outperform-on-terns-pharma-maintains-20-price-target
JMP Securities Reiterates Market Outperfor...
04/21/2025 16:32:35

JMP Securities analyst Silvan Tuerkcan reiterates Terns Pharma (NASDAQ:TERN) with a Market Outperform and maintains $20 pric...

terns-pharma-q4-2024-gaap-eps-024-beats-030-estimate
Terns Pharma Q4 2024 GAAP EPS $(0.24) Beat...
03/20/2025 20:17:26

Terns Pharma (NASDAQ:TERN) reported quarterly losses of $(0.24) per share which beat the analyst consensus estimate of $(0.30) ...

william-blair-initiates-coverage-on-terns-pharma-with-market-perform-rating
William Blair Initiates Coverage On Terns ...
02/28/2025 12:08:59

William Blair analyst Andy Hsieh initiates coverage on Terns Pharma (NASDAQ:TERN) with a Market Perform rating.

terns-pharmaceuticals-appoints-andrew-gengos-as-chief-financial-officer-effective-immediately
Terns Pharmaceuticals Appoints Andrew Geng...
02/24/2025 21:13:18

Terns Pharmaceuticals, Inc. ("Terns" or the "Company") (NASDAQ:TERN), a clinical-stage biopharmaceutical compan...

Core News & Articles
FDA Says Novo Nordisk's Ozempic Injection ...
02/21/2025 14:22:44

Core News & Articles
"Weight-Loss Drug Craze Appears To Be Curb...
12/13/2024 16:16:42

https://www.bloomberg.com/news/articles/2024-12-13/ozempic-craze-appears-to-be-curbing-us-obesity-epidemic

jmp-securities-reiterates-market-outperform-on-terns-pharma-maintains-20-price-target
JMP Securities Reiterates Market Outperfor...
12/04/2024 16:22:13

JMP Securities analyst Silvan Tuerkcan reiterates Terns Pharma (NASDAQ:TERN) with a Market Outperform and maintains $20 pric...

hc-wainwright--co-reiterates-neutral-on-terns-pharma-maintains-75-price-target
HC Wainwright & Co. Reiterates Neutral on ...
12/04/2024 11:57:52

HC Wainwright & Co. analyst Ed Arce reiterates Terns Pharma (NASDAQ:TERN) with a Neutral and maintains $7.5 price target.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION